ERY-TAB
- Product NDC
- 50090-0339
- 11-digit product format
- 500900339
- Labeler code
- 50090
- Product ID
- 50090-0339_b5f23ae8-c8d5-47b8-bca4-7001faedaea3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Erythromycin
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA062298
- Marketing category
- ANDA
- Marketing start
- 2011-04-18
- Marketing end
- 0000-00-00
- Substance
- ERYTHROMYCIN
- Active strength
- 333 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d329c2e1-5ae8-4e64-aea0-77ecea3fa1ab | Product name | 3 | 20250717 |
| 3b331500-3b74-bd2b-fede-d46839f2f4d5 | Product name | 6 | 20240313 |
| fdae2630-eae0-4769-abfd-8f33d5b771b4 | Product name | 3 | 20240202 |
| 8c898317-b543-1e4e-254f-84cec2f3f57e | Product name | 2 | 20191002 |
| 64ae94c0-3212-d73a-92da-9e6dd85c6ebe | Product name | 2 | 20180118 |
| edcfa1cf-915f-1a4c-d0aa-508cc66e70d9 | Product name | 2 | 20170816 |
| ad75fcfd-a339-42a1-9c60-43ba2c654cfa | Product name | 1 | 20170810 |
| 57850177-5927-151f-e1fa-7e2ca47f81e5 | Product name | 1 | 20140508 |
| 8ee71591-1d8f-e24e-242b-bfef131e3168 | Product name | 1 | 20140508 |
| bff5cf99-0f45-fa15-2a76-b160c3c4cc3c | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50090-0339-0 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3ed4-0266-e053-dadaa90a7c1a | ERY-TAB ® (ERYTHROMYCIN DELAYED-RELEASE TABLETS, USP) ENTERIC-COATED |
| 50090-0339-3 | 2023-01-30 | C162847 | 48780-1 | f386c64a-3ed4-0266-e053-dadaa90a7c1a | ERY-TAB ® (ERYTHROMYCIN DELAYED-RELEASE TABLETS, USP) ENTERIC-COATED |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-0339-0 | ERY-TAB | 30 in 1 BOTTLE | TABLET, DELAYED RELEASE | 30 | 15 | |
| 50090-0339-3 | ERY-TAB | 21 in 1 BOTTLE | TABLET, DELAYED RELEASE | 21 | 15 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-0339-0 | EA - Each | 50090-0339 | 45a14a85-8883-45d4-b16c-cc4f9d8e477e | 1 | 2018-09-05 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-0339 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [A-S MEDICATION SOLUTIONS] | 15 | Legacy NDC, 2 package rows | 20210219_ff20121d-63cb-4248-9f7d-43607e255852.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 206078 | ERY-TAB 333 MG Delayed Release Oral Tablet | PSN | ff20121d-63cb-4248-9f7d-43607e255852 | 15 |
| 315090 | erythromycin 333 MG Delayed Release Oral Tablet | PSN | ff20121d-63cb-4248-9f7d-43607e255852 | 15 |
| 206078 | erythromycin 333 MG Delayed Release Oral Tablet [Ery-Tab] | SBD | ff20121d-63cb-4248-9f7d-43607e255852 | 15 |
| 315090 | erythromycin 333 MG Delayed Release Oral Tablet | SCD | ff20121d-63cb-4248-9f7d-43607e255852 | 15 |
| 206078 | Ery-Tab 333 MG Delayed Release Oral Tablet | SY | ff20121d-63cb-4248-9f7d-43607e255852 | 15 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-0339-0 | 50090033900 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (50090-0339-0) | 2016-06-29 | 0000-00-00 | No | No | Current |
| 50090-0339-3 | 50090033903 | 21 TABLET, DELAYED RELEASE in 1 BOTTLE (50090-0339-3) | 2016-06-29 | 0000-00-00 | No | No | Current |